Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390–bisFv(UCHT1)

By Woo Jung   Bour Sarah   Dang Tony   Lee Yu-Jen   Park Seong   Andreas Elissa   Kang Soo   Liu Jen-Sing   Neville David   Frankel Arthur  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 8, 2008-08 ,pp. : 1225-1239

Springer Publishing Company

Access to resources Recommend Favorite

Synergistic Interaction between an Anti-p185 HER-2 Pseudomonas Exotoxin Fusion Protein [scFv(FRP5)-ETA] and Ionizing Radiation for Inhibiting Growth of Ovarian Cancer Cells That Overexpress HER-2

By Schmidt M.   McWatters A.   White R.A.   Groner B.   Wels W.   Fan Z.   Bast R.C.  

Gynecologic Oncology, Vol. 80, Iss. 2, 2001-02 ,pp. : 145-155

Elsevier

Access to resources Recommend Favorite

Targeted therapy of carcinomas using BR96 sFv-PE40, a single-chain immunotoxin that binds to the Le antigen

By Siegall C.B.  

Seminars in Cancer Biology, Vol. 6, Iss. 5, 1995-10 ,pp. : 289-295

Academic Press

Access to resources Recommend Favorite

Evaluation of MAGE A1 in oral squamous cell carcinoma

By            

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1843-1848

Spandidos Publications

Access to resources Recommend Favorite

MAGE-1/Heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivo

By Ge Wei   Sui Yan-Fang   Wu Dao-Cheng   Sun Yu-Jing   Chen Guang-Sheng   Li Zeng-Shan   Si Shao-Yan   Hu Pei-Zhen   Huang Yang   Zhang Xiu-Min  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 7, 2006-07 ,pp. : 841-849

Springer Publishing Company

Access to resources Recommend Favorite